Diosmin Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Diosmin interacts with medications. The heart of this page is the interaction list — every drug Diosmin is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Diosmin is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Diosmin against your medication
Add one medicationDiosmin Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a clinically significant Diosmin drug interaction appears low to moderate for most people, since no interaction is rated major. Every listed interaction is rated moderate, and many rest on theory about how diosmin may affect the enzymes and transporters the body uses to clear medications.
The best-documented concern is carbamazepine, a seizure medicine. A human study found diosmin raised its blood levels and slowed its clearance, which could matter for seizure control. Similar human studies showed higher levels of diclofenac, chlorzoxazone, and fexofenadine when taken after diosmin. There is also one report of serious bleeding in an older woman taking warfarin, aspirin, and diosmin together, so people on blood thinners deserve extra care even though that evidence is limited.
The long list of interacting medications mostly comes from a few broad drug-processing pathways that diosmin may inhibit, so a medication can appear on it based on theory alone. Lab findings even conflict for one of these pathways. Only a handful of medicines have actually been studied with diosmin in people, and the observed changes were moderate, not dangerous.
Based on HelloPharmacist’s Diosmin interaction data and reviewed under our editorial standards.
Drugs that interact with Diosmin
885 medications have a known interaction with Diosmin, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Diosmin using our pharmacist-reviewed interaction data.
AI summaries are generated from our Diosmin interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Diosmin combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Diosmin affects
Every type of medication (drug category) Diosmin is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Anticoagulant/Antiplatelet Drugs
Theoretically, diosmin may increase the risk of bleeding if used with anticoagulant or antiplatelet drugs.
A case of spontaneous intraventricular hemorrhage has been reported for a 77-year-old female after 6 weeks of warfarin therapy, despite an international normalized ratio (INR) of only 1.8. The patient had also been taking aspirin and diosmin for several years. Experts speculate that chronic intake of diosmin predisposed the patient to spontaneous intraventricular hemorrhage by inducing chronic microcirculatory hypertension and inhibiting platelet aggregation. The presence of aspirin was also thought to play a role in this event.
Carbamazepine (Tegretol)
Theoretically, diosmin might reduce the effects of carbamazepine and increase the risk for convulsions.
A pharmacokinetic study in humans shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of carbamazepine 200 mg increases blood levels of carbamazepine by approximately 58% and decreases carbamazepine clearance by 42%. It also decreases the formation of carbamazepine's active metabolite. It is speculated that diosmin reduces the metabolism of carbamazepine by inhibiting cytochrome P450 3A4 (CYP3A4).
Chlorzoxazone (Parafon Forte, Paraflex)
Theoretically, diosmin might increase the levels and clinical effects of chlorzoxazone.
A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of chlorzoxazone 250 mg increases blood levels of chlorzoxazone by 53% and decreases chlorzoxazone clearance by 40%. It is speculated that diosmin reduces the metabolism of chlorzoxazone by inhibiting cytochrome P450 2E1 (CYP2E1).
Cytochrome P450 2C9 (Cyp2C9) Substrates
Theoretically, diosmin might inhibit the metabolism of CYP2C9 substrates.
Diclofenac is metabolized by CYP2C9 enzymes. Clinical and laboratory research shows that diosmin inhibits the metabolism of diclofenac. A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of diclofenac 100 mg increases blood levels of diclofenac and decreases diclofenac clearance.
Cytochrome P450 2E1 (Cyp2E1) Substrates
Theoretically, diosmin might inhibit the metabolism of CYP2E1 substrates.
Chlorzoxazone is metabolized by CYP2E1 enzymes. A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of chlorzoxazone (Paraflex 250) 250 mg increases blood levels of chlorzoxazone by 34% and decreases chlorzoxazone clearance by 40%. It is speculated that diosmin reduces the metabolism of chlorzoxazone by inhibiting CYP2E1.
Cytochrome P450 3A4 (Cyp3A4) Substrates
Theoretically, diosmin might inhibit the metabolism of CYP3A4 substrates.
Laboratory research is conflicting with respect to the effects of diosmin on CYP3A4. Some research suggests that diosmin does not affect CYP3A4 activity. However, other research suggests that diosmin alters the metabolism of carbamazepine, a CYP3A4 substrate. Laboratory and animal research show that oral administration of diosmin for 7 days prior to oral administration of carbamazepine increases plasma concentrations of carbamazepine, decreases the clearance of carbamazepine, and decreases the formation of carbamazepine's active metabolite. Additionally, pharmacokinetic research in healthy male subjects shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of carbamazepine 200 mg increases blood levels of carbamazepine by approximately 58% and decreases carbamazepine clearance by 42%. It is speculated that diosmin reduces the metabolism of carbamazepine by inhibiting CYP3A4. Diosmetin, a metabolite of diosmin, may also inhibit CYP3A4.
Diclofenac (Voltaren, Others)
Theoretically, diosmin might increase the levels and clinical effects of diclofenac.
Clinical and laboratory research shows that diosmin inhibits the metabolism of diclofenac. A pharmacokinetic study in humans shows that taking diosmin (Venex 500) 500 mg daily for 9 days prior to oral administration of diclofenac 100 mg increases blood levels of diclofenac and decreases diclofenac clearance. It is speculated that diosmin reduces the metabolism of diclofenac by inhibiting cytochrome P450 2C9 (CYP2C9).
Fexofenadine (Allegra)
Theoretically, diosmin might increase the levels and clinical effects of fexofenadine.
A pharmacokinetic study in humans shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of fexofenadine 120 mg increases blood levels of fexofenadine by approximately 49% and decreases the apparent oral clearance of fexofenadine by 41%. The time taken to reach maximum plasma concentration, the half-life, and the apparent renal clearance of fexofenadine are not affected. For this reason, it is speculated that diosmin alters the pharmacokinetics of fexofenadine via inhibition of P-glycoprotein in the intestine, but not in the kidney or liver.
P-Glycoprotein Substrates
Theoretically, diosmin might increase levels of drugs that are substrates of P-glycoprotein (P-gp).
Preliminary laboratory research suggests that diosmin inhibits P-gp. Additionally, pharmacokinetic research in healthy male subjects shows that taking diosmin (Venex) 500 mg daily for 10 days prior to oral administration of fexofenadine 120 mg increases blood levels of fexofenadine, a P-gp substrate, by approximately 49% and decreases the apparent oral clearance of fexofenadine by 41%. The time taken to reach maximum plasma concentration, the half-life, and the apparent renal clearance of fexofenadine are not affected. For this reason, it is speculated that diosmin inhibits P-gp in the intestine, but not in the kidney or liver.
Diosmin: Uses, Safety & Side Effects
Diosmin is a citrus-derived flavonoid most often used for vein-related problems such as chronic venous insufficiency and hemorrhoids, and it is usually combined with a related flavonoid called hesperidin. Some studies suggest it may help relieve leg swelling and hemorrhoid symptoms, but quality varies. Talk to your pharmacist or doctor before starting it, especially if you are pregnant or breastfeeding.
- Part used
- A flavonoid derived from citrus fruit peels (often made from hesperidin)
- Common forms
- Tablets, capsules (often combined with hesperidin)
- Chronic venous insufficiency
- Hemorrhoids
- Leg swelling and heaviness
- Varicose veins
- Spider veins
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally well tolerated short-term, but long-term safety is less well studied.
When used orally in amounts found in foods.
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Diosmin is a plant compound called a flavonoid. It is found naturally in some citrus fruits and is usually made commercially from the peels of oranges or other citrus, often by converting a related flavonoid called hesperidin.
It is most often sold as a supplement or, in some countries, as a prescription medicine for vein problems. Many products combine diosmin with hesperidin in a mixture sometimes labeled as a "micronized purified flavonoid fraction."
People most commonly take diosmin to support healthy blood flow in the legs and to ease symptoms tied to veins, such as swelling, heaviness, and hemorrhoids.
How it works
Diosmin is thought to work mainly by improving the tone and strength of vein walls and by reducing leakiness of small blood vessels. This may help blood and fluid move better and reduce swelling.
Laboratory and animal studies suggest it may also reduce inflammation, protect the lining of blood vessels, and improve lymph flow. Some research suggests it has antioxidant effects as well.
It is important to know that many of these proposed mechanisms come from laboratory and animal research, and how strongly they apply in the human body is not fully understood.
Does Diosmin work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Possibly Effective Chronic venous insufficiency (CVI)
Oral diosmin, as part of a micronized purified flavonoid fraction, seems to be beneficial for reducing symptoms of CVI. It is unclear if oral diosmin alone is beneficial.
Possibly Effective Hemorrhoids
Oral diosmin, as part of a micronized purified flavonoid fraction (MPFF) or in combination with other compounds, seems to be beneficial for hemorrhoids.
Possibly Effective Venous leg ulcers
Oral diosmin, as part of a micronized purified flavonoid fraction, seems to be beneficial for venous leg ulcers.
Also studied for 15 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Back pain
It is unclear if oral diosmin is beneficial for back pain.
Insufficient Reliable Evidence To Rate Chronic prostatitis and chronic pelvic pain syndrome (CP/CPPS)
It is unclear if oral diosmin, as part of a micronized purified flavonoid fraction, is beneficial for CPPS.
Insufficient Reliable Evidence To Rate Coronary artery bypass graft (CABG) surgery
It is unclear if oral diosmin, as part of a micronized purified flavonoid fraction, is beneficial for patients undergoing CABG surgery.
Insufficient Reliable Evidence To Rate Diabetes
It is unclear if oral diosmin, as part of a micronized purified flavonoid fraction or in combination with other compounds, is beneficial for diabetes.
Insufficient Reliable Evidence To Rate Diabetic neuropathy
It is unclear if oral diosmin is beneficial for diabetic neuropathy.
Insufficient Reliable Evidence To Rate Lymphedema
It is unclear if oral diosmin, as part of a micronized purified flavonoid fraction or in combination with other compounds, is beneficial for lymphedema.
Insufficient Reliable Evidence To Rate Menorrhagia
It is unclear if oral micronized diosmin is beneficial for menorrhagia.
Insufficient Reliable Evidence To Rate Metabolic syndrome
It is unclear if oral diosmin is beneficial for metabolic syndrome.
Insufficient Reliable Evidence To Rate Minor bleeding
It is unclear if oral diosmin, as part of a micronized purified flavonoid fraction, is beneficial for minor bleeding.
Insufficient Reliable Evidence To Rate Ovarian hyperstimulation syndrome
It is unclear if oral diosmin is beneficial for reducing the occurrence of ovarian hyperstimulation syndrome.
Insufficient Reliable Evidence To Rate Postoperative pain
It is unclear if oral diosmin reduces postoperative pain.
Insufficient Reliable Evidence To Rate Postoperative swelling
It is unclear if oral diosmin is beneficial for postoperative swelling.
Insufficient Reliable Evidence To Rate Varicose veins
It is unclear if oral diosmin, as part of a micronized purified flavonoid fraction, is beneficial for varicose veins.
Insufficient Reliable Evidence To Rate Venous thromboembolism (VTE)
It is unclear if oral diosmin is beneficial for prevention of VTE.
Insufficient Reliable Evidence To Rate Vincristine-induced neuropathy
Oral diosmin has only been evaluated in combination with other ingredients; its effect when used alone is unclear.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
Diosmin appears to be generally well tolerated when taken by mouth for short periods. However, its long-term safety has not been thoroughly studied.
People with stomach or bowel sensitivity may notice digestive upset. If you have a medical condition or take other medicines, check with your pharmacist or doctor first.
For pregnancy, there is not enough reliable safety information, so diosmin should be used only if a doctor advises it. For breastfeeding, information is also lacking, so it is safer to avoid it. As with any supplement, talk to a healthcare professional before starting.
Side effects
Most reported side effects are mild. They can include stomach upset, nausea, diarrhea, and headache. Some people may notice dizziness or skin reactions.
Serious side effects appear to be uncommon, but because supplements are not tightly regulated, product quality can vary. Stop taking diosmin and seek medical care if you have signs of an allergic reaction, such as rash, itching, swelling, or trouble breathing.
Diosmin: Reported Adverse Effects
Documented safety reports on Diosmin from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Orally, diosmin is generally well tolerated.
Most Common Adverse Effects:
Orally: Abdominal pain, diarrhea, dizziness, gastritis, nausea, skin inflammation, and skin redness.
Serious Adverse Effects (Rare):
Orally: Cardiac arrhythmias and hemolytic anemia.
Anemia Hematologic
Arrhythmia Cardiovascular
Orally, diosmin can cause cardiac arrhythmias.
- Milano G, Leone S, Fucile C, Zuccoli ML, Stimamiglio A, Martelli A, Mattioli F. Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports. J Med Case Rep. 2014 Jun 16;8:194.
- Steinbruch M, Nunes C, Gama R, et al. Is nonmicronized diosmin 600?mg as effective as micronized diosmin 900?mg plus hesperidin 100?mg on chronic venous disease symptoms? Results of a noninferiority study. Int J Vasc Med. 2020;2020:4237204.
Cluster headache Neurologic/CNS
Orally, diosmin can cause headache, low energy, and dizziness in some patients.
- Misra MC, Parshad R. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids. Br J Surgery 2000;87:868-72.
- Thanapongsathorn W, Vajrabukka T. Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids. Dis Colon Rectum 1992;35:1085-8.
- Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 1994;45:566-73.
- Guilhou JJ, Dereure O, Marzin L, et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997;48:77-85..
- Milano G, Leone S, Fucile C, Zuccoli ML, Stimamiglio A, Martelli A, Mattioli F. Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports. J Med Case Rep. 2014 Jun 16;8:194.
- Steinbruch M, Nunes C, Gama R, et al. Is nonmicronized diosmin 600?mg as effective as micronized diosmin 900?mg plus hesperidin 100?mg on chronic venous disease symptoms? Results of a noninferiority study. Int J Vasc Med. 2020;2020:4237204.
- Mansilha A, Caldevilla H, Puskás A, Lucien A, Roby L, Kirienko A. MPFF 1000 mg chewable once daily vs. MPFF 500 mg twice daily in chronic venous disease: the double-blind, randomized, non-inferiority CHEWY trial. Int Angiol 2022;41(6):464-475.
Diarrhea Gastrointestinal
Orally, diosmin can cause gastrointestinal side effects, including abdominal pain, diarrhea, nausea, flatulence, and gastritis. In one case, exacerbation of chronic colopathy was reported after taking a specific diosmin-containing product (Daflon 500, Les Laboratoires Servier).
- Misra MC, Parshad R. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids. Br J Surgery 2000;87:868-72.
- Thanapongsathorn W, Vajrabukka T. Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids. Dis Colon Rectum 1992;35:1085-8.
- Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 1994;45:566-73.
- Guilhou JJ, Dereure O, Marzin L, et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997;48:77-85..
- Cospite, M. and Dominici, A. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Int Angiol. 1989;8(4 Suppl):61-65.
- Buckshee, K., Takkar, D., and Aggarwal, N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet 1997;57(2):145-151.
- Milano G, Leone S, Fucile C, Zuccoli ML, Stimamiglio A, Martelli A, Mattioli F. Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports. J Med Case Rep. 2014 Jun 16;8:194.
- Gavrilov SG, Karalkin AV, Moskalenko YP, Grishenkova AS. Efficacy of two micronized purified flavonoid fraction dosing regimens in the pelvic venous pain relief. Int Angiol. 2021;40(3):180-186.
- Steinbruch M, Nunes C, Gama R, et al. Is nonmicronized diosmin 600?mg as effective as micronized diosmin 900?mg plus hesperidin 100?mg on chronic venous disease symptoms? Results of a noninferiority study. Int J Vasc Med. 2020;2020:4237204.
- Schastlivtsev I, Lobastov K, Barinov V, Kanzafarova I. Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study. Int Angiol. 2020;39(5):361-371.
- Mansilha A, Caldevilla H, Puskás A, Lucien A, Roby L, Kirienko A. MPFF 1000 mg chewable once daily vs. MPFF 500 mg twice daily in chronic venous disease: the double-blind, randomized, non-inferiority CHEWY trial. Int Angiol 2022;41(6):464-475.
Pain Musculoskeletal
Orally, one case report of muscle pain was thought to be related to diosmin use.
Urticaria Dermatologic
Orally, diosmin can cause skin redness, hives, itchiness, and inflammation.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single official dose of diosmin for supplement use. It is often sold combined with hesperidin in standardized products, and the right amount can depend on the condition and the specific product.
The best approach is to follow the directions on the product label and check with your pharmacist or doctor before starting. Do not assume that taking more will work better or be safer.
Diosmin & Pregnancy
Diosmin & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 20 references that drive our Diosmin monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Misra MC, Parshad R. Randomized clinical trial of micronized flavonoids in the early control of bleeding from acute internal haemorrhoids. Br J Surgery 2000;87:868-72. PubMed
- Thanapongsathorn W, Vajrabukka T. Clinical trial of oral diosmin (Daflon) in the treatment of hemorrhoids. Dis Colon Rectum 1992;35:1085-8. PubMed
- Cospite M. Double-blind, placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 1994;45:566-73.
- Guilhou JJ, Dereure O, Marzin L, et al. Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 1997;48:77-85.. PubMed
- Cospite, M. and Dominici, A. Double blind study of the pharmacodynamic and clinical activities of 5682 SE in venous insufficiency. Advantages of the new micronized form. Int Angiol. 1989;8(4 Suppl):61-65.
- Buckshee, K., Takkar, D., and Aggarwal, N. Micronized flavonoid therapy in internal hemorrhoids of pregnancy. Int J Gynaecol Obstet 1997;57(2):145-151. PubMed
- Kumar RM, Van Gompel JJ, Bower R, Rabinstein AA. Spontaneous intraventricular hemorrhage associated with prolonged diosmin therapy. Neurocrit Care. 2011 Jun;14(3):438-40. PubMed
- Milano G, Leone S, Fucile C, Zuccoli ML, Stimamiglio A, Martelli A, Mattioli F. Uncommon serum creatine phosphokinase and lactic dehydrogenase increase during diosmin therapy: two case reports. J Med Case Rep. 2014 Jun 16;8:194. PubMed
- Rajnarayana K, Venkatesham A, Krishna DR. Bioavailability of diclofenac sodium after pretreatment with diosmin in healthy volunteers. Drug Metabol Drug Interact. 2007;22(2-3):165-74. PubMed
- Rajnarayana K, Venkatesham A, Nagulu M, Srinivas M, Krishna DR. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers. Drug Metabol Drug Interact. 2008;23(3-4):311-21. PubMed
- Yoo HH, Lee M, Chung HJ, Lee SK, Kim DH. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 cells. J Agric Food Chem. 2007 Sep 5;55(18):7620-5. PubMed
- Bedada SK, Neerati P. Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(2):115-21. PubMed
- Burkina V, Zlabek V, Halsne R, Ropstad E, Zamaratskaia G. In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish. Biochem Pharmacol. 2016;110-111:109-16 PubMed
- Bedada SK, Boga PK. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects. Xenobiotica. 2017;47(10):879-84. PubMed
- Bedada SK, Boga PK, Kotakonda HK. The effect of diosmin on the pharmacokinetics of fexofenadine in healthy human volunteers. Xenobiotica. 2017;47(3):230-35. PubMed
- Poór M, Boda G, Mohos V, et al. Pharmacokinetic interaction of diosmetin and silibinin with other drugs: Inhibition of CYP2C9-mediated biotransformation and displacement from serum albumin. Biomed Pharmacother. 2018;102:912-921. PubMed
- Gavrilov SG, Karalkin AV, Moskalenko YP, Grishenkova AS. Efficacy of two micronized purified flavonoid fraction dosing regimens in the pelvic venous pain relief. Int Angiol. 2021;40(3):180-186. PubMed
- Steinbruch M, Nunes C, Gama R, et al. Is nonmicronized diosmin 600?mg as effective as micronized diosmin 900?mg plus hesperidin 100?mg on chronic venous disease symptoms? Results of a noninferiority study. Int J Vasc Med. 2020;2020:4237204. PubMed
- Schastlivtsev I, Lobastov K, Barinov V, Kanzafarova I. Diosmin 600 in adjunction to rivaroxaban reduces the risk of post-thrombotic syndrome after femoropopliteal deep vein thrombosis: results of the RIDILOTT DVT study. Int Angiol. 2020;39(5):361-371. PubMed
- Mansilha A, Caldevilla H, Puskás A, Lucien A, Roby L, Kirienko A. MPFF 1000 mg chewable once daily vs. MPFF 500 mg twice daily in chronic venous disease: the double-blind, randomized, non-inferiority CHEWY trial. Int Angiol 2022;41(6):464-475. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with Diosmin
60 brands in our database make a supplement containing Diosmin.
Supplement products with Diosmin
121 products in our database contain Diosmin. Open any to see its full ingredient list and every drug interaction we check.
Diosmin: Common Questions
What is Diosmin used for, and does it work?
Does Diosmin interact with prescription medications?
How are Diosmin interactions rated?
Is it safe to take Diosmin with my medications?
Where does this Diosmin interaction information come from?
What is Diosmin used for?
Is Diosmin the same as hesperidin?
Is Diosmin safe to take?
Can I take Diosmin while pregnant or breastfeeding?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain Diosmin
A rotating sample of real supplements in our database that list Diosmin — open any to see its full ingredients and every drug interaction we check.
- Diosmin Hesperidin 1000 mg by Mental Refreshment
- Omega-3 + Vitamins C & D by Purity Products
- Diosmin & Hesperidin by Herbs SRA
- Circulation & Vein Support for Healthy Legs by ProCaps
- Vein Support by Zoi Research
- Vasoflex D1 by Kramer Novis
- Leg Vein Support by Roex
- Lovely Legs by Garden of Life Extraordinary Beauty
- Propadrol EP by EST
- Circulation & Vein Formula by SigmaCeutical
Have a question about Diosmin?
Our pharmacists answer your medication & supplement questions — free.